Prostate Cancer Minimally Invasive Surgery Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Prostate Cancer Minimally Invasive Surgery Market to 2027 - Global Analysis and Forecasts by Procedure (Laparoscopic Prostatectomy, Brachytherapy, Cryosurgery, others); Stages Of Disease Progression (Stage A, Stage B, Stage C, Stage D); End User (Hospitals and Clinics, Diagnostic Centers, Others) and Geography

Report Code: TIPRE00003526 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Prostate cancer is the cancer affecting the prostate glands in men. It is the second most common cancer after skin cancer in men. Some of the common factors responsible for the onset of prostate cancer are, old age, family history, and race. As per survey, prostate cancer is, mostly observed in men above 50 years of age. During recent years, the availability of advanced techniques for screening and diagnosis has significantly reduced the cases of prostate cancer.

MARKET DYNAMICS
The prostate cancer minimally invasive surgery market is anticipated to grow in the forecast, owing to rising prevalence of prostate cancer as well as the increasing preference for minimally invasive surgeries. In addition, improved healthcare facilities and infrastructure in developing economies is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Prostate Cancer Minimally Invasive Surgery Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of prostate cancer minimally invasive surgery market with detailed market segmentation by procedure, stages of disease progression, end user, and geography. The global prostate cancer minimally invasive surgery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prostate cancer minimally invasive surgery market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global prostate cancer minimally invasive surgery market is segmented on the basis of procedure, stages of disease progression and end user. Based on procedure, the market is segmented as laparoscopic prostatectomy, brachytherapy, cryosurgery, and others. On the basis of stages of disease progression, the global prostate cancer minimally invasive surgery market is segmented into, stage A, stage B, stage C, and stage D. Similarly, based on end user, the market is categorized as, hospitals and clinics, diagnostic centers, and others
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prostate cancer minimally invasive surgery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prostate cancer minimally invasive surgery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate cancer minimally invasive surgery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate cancer minimally invasive surgery market in these regions.

MARKET PLAYERS
The reports cover key developments in the prostate cancer minimally invasive surgery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from prostate cancer minimally invasive surgery market are anticipated to lucrative growth opportunities in the future with the rising demand for prostate cancer minimally invasive surgery market in the global market. Below mentioned is the list of few companies engaged in the prostate cancer minimally invasive surgery market.

The report also includes the profiles of key prostate cancer minimally invasive surgery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Theragenics Corporation
  • Varian Medical Systems, Inc.,
  • C.R. Bard Inc.,
  • Intuitive Surgical
  • Siemens Healthineers
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Minimally Invasive Surgery Market - By Procedure
1.3.2 Prostate Cancer Minimally Invasive Surgery Market - By Stages Of Disease Progression
1.3.3 Prostate Cancer Minimally Invasive Surgery Market - By End User
1.3.4 Prostate Cancer Minimally Invasive Surgery Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER MINIMALLY INVASIVE SURGERY - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER MINIMALLY INVASIVE SURGERY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET - REVENUE AND FORECASTS TO 2027 - PROCEDURE
7.1. OVERVIEW
7.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
7.3. LAPAROSCOPIC PROSTATECTOMY
7.3.1. Overview
7.3.2. Laparoscopic Prostatectomy Market Forecast and Analysis
7.4. BRACHYTHERAPY
7.4.1. Overview
7.4.2. Brachytherapy Market Forecast and Analysis
7.5. CRYOSURGERY
7.5.1. Overview
7.5.2. Cryosurgery Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. others Market Forecast and Analysis
8. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET - REVENUE AND FORECASTS TO 2027 - STAGES OF DISEASE PROGRESSION
8.1. OVERVIEW
8.2. STAGES OF DISEASE PROGRESSION MARKET FORECASTS AND ANALYSIS
8.3. STAGE A
8.3.1. Overview
8.3.2. Stage A Market Forecast and Analysis
8.4. STAGE B
8.4.1. Overview
8.4.2. Stage B Market Forecast and Analysis
8.5. STAGE C
8.5.1. Overview
8.5.2. Stage C Market Forecast and Analysis
8.6. STAGE D
8.6.1. Overview
8.6.2. Stage D Market Forecast and Analysis
9. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Prostate Cancer Minimally Invasive Surgery Market Overview
10.1.2 North America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis
10.1.3 North America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Procedure
10.1.4 North America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Stages Of Disease Progression
10.1.5 North America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By End User
10.1.6 North America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Countries
10.1.6.1 United States Prostate Cancer Minimally Invasive Surgery Market
10.1.6.1.1 United States Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.1.6.1.2 United States Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.1.6.1.3 United States Prostate Cancer Minimally Invasive Surgery Market by End User
10.1.6.2 Canada Prostate Cancer Minimally Invasive Surgery Market
10.1.6.2.1 Canada Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.1.6.2.2 Canada Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.1.6.2.3 Canada Prostate Cancer Minimally Invasive Surgery Market by End User
10.1.6.3 Mexico Prostate Cancer Minimally Invasive Surgery Market
10.1.6.3.1 Mexico Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.1.6.3.2 Mexico Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.1.6.3.3 Mexico Prostate Cancer Minimally Invasive Surgery Market by End User
10.1.6.4 US Prostate Cancer Minimally Invasive Surgery Market
10.1.6.4.1 US Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.1.6.4.2 US Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.1.6.4.3 US Prostate Cancer Minimally Invasive Surgery Market by End User
10.2. EUROPE
10.2.1 Europe Prostate Cancer Minimally Invasive Surgery Market Overview
10.2.2 Europe Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis
10.2.3 Europe Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Procedure
10.2.4 Europe Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Stages Of Disease Progression
10.2.5 Europe Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By End User
10.2.6 Europe Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Prostate Cancer Minimally Invasive Surgery Market
10.2.6.1.1 Germany Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.2.6.1.2 Germany Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.2.6.1.3 Germany Prostate Cancer Minimally Invasive Surgery Market by End User
10.2.6.2 France Prostate Cancer Minimally Invasive Surgery Market
10.2.6.2.1 France Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.2.6.2.2 France Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.2.6.2.3 France Prostate Cancer Minimally Invasive Surgery Market by End User
10.2.6.3 Italy Prostate Cancer Minimally Invasive Surgery Market
10.2.6.3.1 Italy Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.2.6.3.2 Italy Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.2.6.3.3 Italy Prostate Cancer Minimally Invasive Surgery Market by End User
10.2.6.4 Spain Prostate Cancer Minimally Invasive Surgery Market
10.2.6.4.1 Spain Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.2.6.4.2 Spain Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.2.6.4.3 Spain Prostate Cancer Minimally Invasive Surgery Market by End User
10.2.6.5 United Kingdom Prostate Cancer Minimally Invasive Surgery Market
10.2.6.5.1 United Kingdom Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.2.6.5.2 United Kingdom Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.2.6.5.3 United Kingdom Prostate Cancer Minimally Invasive Surgery Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Overview
10.3.2 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis
10.3.3 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Procedure
10.3.4 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Stages Of Disease Progression
10.3.5 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Prostate Cancer Minimally Invasive Surgery Market
10.3.6.1.1 Australia Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.3.6.1.2 Australia Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.3.6.1.3 Australia Prostate Cancer Minimally Invasive Surgery Market by End User
10.3.6.2 China Prostate Cancer Minimally Invasive Surgery Market
10.3.6.2.1 China Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.3.6.2.2 China Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.3.6.2.3 China Prostate Cancer Minimally Invasive Surgery Market by End User
10.3.6.3 India Prostate Cancer Minimally Invasive Surgery Market
10.3.6.3.1 India Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.3.6.3.2 India Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.3.6.3.3 India Prostate Cancer Minimally Invasive Surgery Market by End User
10.3.6.4 Japan Prostate Cancer Minimally Invasive Surgery Market
10.3.6.4.1 Japan Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.3.6.4.2 Japan Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.3.6.4.3 Japan Prostate Cancer Minimally Invasive Surgery Market by End User
10.3.6.5 South Korea Prostate Cancer Minimally Invasive Surgery Market
10.3.6.5.1 South Korea Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.3.6.5.2 South Korea Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.3.6.5.3 South Korea Prostate Cancer Minimally Invasive Surgery Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Overview
10.4.2 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis
10.4.3 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Procedure
10.4.4 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Stages Of Disease Progression
10.4.5 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Prostate Cancer Minimally Invasive Surgery Market
10.4.6.1.1 South Africa Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.4.6.1.2 South Africa Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.4.6.1.3 South Africa Prostate Cancer Minimally Invasive Surgery Market by End User
10.4.6.2 Saudi Arabia Prostate Cancer Minimally Invasive Surgery Market
10.4.6.2.1 Saudi Arabia Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.4.6.2.2 Saudi Arabia Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.4.6.2.3 Saudi Arabia Prostate Cancer Minimally Invasive Surgery Market by End User
10.4.6.3 U.A.E Prostate Cancer Minimally Invasive Surgery Market
10.4.6.3.1 U.A.E Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.4.6.3.2 U.A.E Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.4.6.3.3 U.A.E Prostate Cancer Minimally Invasive Surgery Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Prostate Cancer Minimally Invasive Surgery Market Overview
10.5.2 South and Central America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis
10.5.3 South and Central America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Procedure
10.5.4 South and Central America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Stages Of Disease Progression
10.5.5 South and Central America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By End User
10.5.6 South and Central America Prostate Cancer Minimally Invasive Surgery Market Forecasts and Analysis - By Countries
10.5.6.1 Argentina Prostate Cancer Minimally Invasive Surgery Market
10.5.6.1.1 Argentina Prostate Cancer Minimally Invasive Surgery Market by Procedure
10.5.6.1.2 Argentina Prostate Cancer Minimally Invasive Surgery Market by Stages Of Disease Progression
10.5.6.1.3 Argentina Prostate Cancer Minimally Invasive Surgery Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET, KEY COMPANY PROFILES
12.1. THERAGENICS CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. VARIAN MEDICAL SYSTEMS, INC.,
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. C.R. BARD INC.,
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INTUITIVE SURGICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SIEMENS HEALTHCARE PRIVATE LIMITED
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Theragenics Corporation
2. Varian Medical Systems, Inc.,
3. C.R. Bard Inc.,
4. Intuitive Surgical
5. Siemens Healthineers
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book